1. Does your trust treat adult multiple myeloma [MM] ? - if you refer your multiple myeloma patients to another centre, please state which.
A) YES
2. If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;
· Bortezomib [Velcade] 33
· Carfilzomib [Kyprolis] 0
· Ixazomib [Ninlaro] 6
· Lenalidomide [Revlimid] 16
· Daratumumab [Darzalex] 6
· Melphalan, prednisolone and thalidomide (known as MPT) 0
· Cyclophosphamide, thalidomide and dexamethasone (known as CTD) 6
· Pomalidomide [Imnovid] 7
Please note – we are able to say how many times this drug has been used but are unable to say what the indication is. The figures provided above are for drug usage only.
3. Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
A) 25
If possible, how many CLL patients treated were new to therapy in the past 3 months?
A) 16
4. How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
· Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR) 3
· Bendamustine and rituximab (known as BR) 6
· Ibrutinib [Imbruvica] 23
· Chlorambucil 4
· Venetoclax 2
· Obinutuzumab 9
· Idelalisib 0
· Fludarabine and rituximab (known as FR) 0
· High-dose prednisone and rituximab 0
· Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR) 0
· Alemtuzumab (Campath) with rituximab 0
Please note – we are able to say how many times this drug has been used but are unable to say what the indication is. The figures provided above are for drug usage only.